Galaxy Surfactants (GALAXYSURF) investor relations material

Executive summary

• Achieved highest-ever quarterly EBITDA of INR 252.5 crores, nearly doubling profitability year-over-year, driven by operational excellence, risk management, and a diversified portfolio.

• Consolidated mid-single digit volume growth, with balanced contributions from Performance Surfactants and Specialty Care segments.

• India led with 11% volume growth, Rest of World up 6%, and APAC delivered double-digit growth; AMET region volumes down 4% year-over-year but up 19% sequentially.

• Innovation milestones included the launch of Simplex and recognition for GalaxSea Earth Biosurf at industry awards.

• Unaudited consolidated and standalone financial results for the quarter ended June 30, 2026, were approved by the Board and reviewed by auditors, with no material misstatements identified.

Financial highlights

• EBITDA for Q1 FY 2027 reached INR 252.5 crores, up from INR 135.1 crores in Q1 FY 2026.

• Consolidated revenue for Q1FY27 rose 38.5% year-over-year to ₹1,785.2 crore, with EBITDA margin improving to 14.1%.

• PAT grew 108.7% year-over-year to ₹165.9 crore, with PAT margin at 9.3%.

• Standalone revenue grew 44.8% year-over-year to ₹1,265.5 crore, and standalone EBITDA rose 111.3% to ₹173.8 crore.

• Basic EPS (consolidated) for the quarter was ₹46.80, up from ₹22.42 year-over-year.

Outlook and guidance

• Maintains full-year volume growth guidance at 6%-8%.

• Full-year EBITDA per metric ton guidance raised to INR 24,000–25,000.

• Expects demand to remain healthy across key markets, supported by festive season in India and improving international momentum.

• Management remains confident in delivering sustainable long-term growth through disciplined execution and customer-centric strategies.

• Cautious on supply chain volatility and geopolitical developments, especially in West Asia.